2014
DOI: 10.1074/jbc.m113.536136
|View full text |Cite
|
Sign up to set email alerts
|

The DrrAB Efflux System of Streptomyces peucetius Is a Multidrug Transporter of Broad Substrate Specificity

Abstract: Background: DrrAB is dedicated to export of doxorubicin in Streptomyces peucetius, an organism that produces this anticancer drug. Whether this prototype system can export other drugs has not been investigated. Results: DrrAB exports multiple drugs efficiently. Conclusion: Substrate specificity of DrrAB overlaps with known bacterial and human multidrug resistance proteins. Significance: This study suggests common mechanisms and origin for DrrAB and other MDR proteins.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
63
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(71 citation statements)
references
References 68 publications
7
63
0
Order By: Relevance
“…We demonstrated substrate polyspecificity in a homologous group of ABC efflux systems that can confer resistance against a spectrum of structurally distinct antibiotics and anticancer drugs. These probable two-component transporters all display moderate sequence homology (30 to 50% shared identity) against the DrrAB multidrug efflux system of the DAU-/DOX-producing Streptomyces peucetius (31) and are predicted to originate from bacteria of diverse phyla, including Actinobacteria, Firmicutes, and Proteobacteria (see Table S3 in the supplemental material). While the identification of novel DrrAB homologues in different bacterial taxa is not unexpected, the ligand promiscuity of these functionally conserved, but sequence-wise diverse, ABC transporters (DrrAB included) raises insightful questions of what drove the development of polyspecific substrate recognition and whether these transporters have shared evolutionary history with similar multidrug efflux system found in now-pathogenic organisms.…”
Section: Figmentioning
confidence: 99%
“…We demonstrated substrate polyspecificity in a homologous group of ABC efflux systems that can confer resistance against a spectrum of structurally distinct antibiotics and anticancer drugs. These probable two-component transporters all display moderate sequence homology (30 to 50% shared identity) against the DrrAB multidrug efflux system of the DAU-/DOX-producing Streptomyces peucetius (31) and are predicted to originate from bacteria of diverse phyla, including Actinobacteria, Firmicutes, and Proteobacteria (see Table S3 in the supplemental material). While the identification of novel DrrAB homologues in different bacterial taxa is not unexpected, the ligand promiscuity of these functionally conserved, but sequence-wise diverse, ABC transporters (DrrAB included) raises insightful questions of what drove the development of polyspecific substrate recognition and whether these transporters have shared evolutionary history with similar multidrug efflux system found in now-pathogenic organisms.…”
Section: Figmentioning
confidence: 99%
“…In some Gram-positive Streptomyces species, known for their production of small-molecule antibiotics and pigments, genes for antibiotic biosynthetic enzymes are found in large clusters, which can also contain genes encoding efflux pumps and regulatory proteins that control expression of adjacent loci. Efflux pumps have been implicated in the transport of, and resistance to, antibiotics such as actinorhodin, daunorubicin, and oxytetracycline in their streptomycete producers (3)(4)(5)(6). In several cases, either the antibiotic itself, an intermediate in antibiotic synthesis, or compounds with structural similarities to the antibiotic have been demonstrated or inferred to be inducers of pump expression (3,4,7,8).…”
mentioning
confidence: 99%
“…Liu et alidentified and isolated nine new pregnane glycosides along with six known compounds from the roots of Cynanchum auriculatum. The most abundantly known pregnane glycoside, wilfoside K1N (10) with similar structures to that of P57 isolated from Hoodia gordonii showed significant appetite suppressing effect, and further led to loss of body weight in rats (34,35). Hovenia acerba vinegar is an anti-obesity product in the market, which is known for its function to lower serum total cholesterol, plasma triglyceride levels and atherogenic index.…”
Section: Appetite Suppressantsmentioning
confidence: 99%